PMID: 6107768Nov 29, 1980Paper

Safety and patient acceptability of intravenous immune globulin in 10% maltose

Lancet
H D OchsR J Wedgwood

Abstract

The safety and patient acceptance of two preparations of modified (reduced and alkylated) immune globulin for intravenous use were evaluated; one preparation was formulated as a 5% solution in 10% maltose (IGIV-maltose), the other did not contain maltose (IGIV). In this double-blind trial each of 29 immunodeficient patients received three consecutive monthly infusions (100 or 150 mg/kg immune globulin) of one preparation before being crossed over to the other. Only 3 of 29 patients had adverse reactions when on IGIV-maltose, compared with 22 who had side-effects during infusions of IGIV (p < 0.001). Adverse reactions were recorded during 3 of 87 IGIV-maltose infusions and during 51 infusions with the maltose-free IGIV (p < 0.001). 27 patients expressed preference for IGIV-maltose. IGIV-maltose seems safe and will permit rapid infusion of large doses of immune globulin, thus improving the management of patients with antibody deficiency diseases.

References

Jan 1, 1977·Nutrition and Metabolism·C Finke, H Reinauer
Aug 1, 1956·Stanford Medical Bulletin·C B FAVOUR
Jan 1, 1962·Vox Sanguinis·S BARANDUNH ISLIKER

❮ Previous
Next ❯

Citations

Apr 1, 1982·Journal of Clinical Immunology·D J WinstonR P Gale
Aug 8, 2002·Current Allergy and Asthma Reports·Melvin Berger
Jan 31, 1981·Lancet
Jul 11, 1991·The New England Journal of Medicine·R H Buckley, R I Schiff
Jan 23, 1992·The New England Journal of Medicine·E Ben-Chetrit, C Putterman
May 1, 1994·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·R I Schiff
Mar 1, 1985·Clinical Immunology and Immunopathology·R W SteeleD J Marmer
Jun 1, 1981·Immunology Today·A R Hayward
Jun 15, 2007·Clinical and Experimental Immunology·P WoodUNKNOWN UK Primary Immunodeficiency Network
Jun 17, 1999·Clinical Obstetrics and Gynecology·A L Clark
Jun 1, 1984·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·C KochV Andersen
Jan 1, 1983·Journal of Clinical Apheresis·P C Dau
Feb 1, 1997·The Annals of Pharmacotherapy·C A HeynemanJ V Beckwith
Feb 16, 1987·The Medical Journal of Australia·R Mansberg, W W Coupland
Jul 1, 1987·The Journal of Infection·J L LundbladG Mitra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.